iShares MSCI Emerging Markets ETF (EEM) – State Street’s 3–5 Year Outperformance Thesis vs. S&P 500 - Healthcare Earnings Report

Live News

As of Monday, May 4, 2026, 09:08 UTC, State Street Global Advisors released its final April 2026 long-term asset class forecasts, identifying two index ETFs—including the iShares MSCI Emerging Markets ETF (EEM)—as likely to outperform the S&P 500 Index (^GSPC) over the 3–5 year investment horizon. On the publication date, EEM traded up 3.20% intraday, while the Vanguard S&P Small-Cap 600 ETF (VIOO) rose 0.58% and the S&P 500 gained 1.46%. State Street projects the S&P 500 will deliver 7.1% annua iShares MSCI Emerging Markets ETF (EEM) – State Street’s 3–5 Year Outperformance Thesis vs. S&P 500{随机描述}{随机描述}iShares MSCI Emerging Markets ETF (EEM) – State Street’s 3–5 Year Outperformance Thesis vs. S&P 500{随机描述}

Key Highlights

iShares MSCI Emerging Markets ETF (EEM) – State Street’s 3–5 Year Outperformance Thesis vs. S&P 500{随机描述}{随机描述}iShares MSCI Emerging Markets ETF (EEM) – State Street’s 3–5 Year Outperformance Thesis vs. S&P 500{随机描述}

Expert Insights

State Street’s forecast represents a strategic pivot from the 2016–2025 period, where U.S. large-cap dominance (driven by the “Magnificent Seven” tech stocks) generated a 15.2% annualized total return for the S&P 500, dwarfing both U.S. small-caps and EM equities. However, a critical unstated caveat in the firm’s recommendation is the impact of ETF expense ratios on net investor returns—a factor that undermines EEM’s viability as an outperforming vehicle. While the MSCI Emerging Markets Index is projected to deliver 7.5% annualized, EEM’s 0.72% expense ratio reduces its net projected return to 6.78%, 29 basis points below the Vanguard S&P 500 ETF’s (VOO) net projected return of 7.07% (7.1% index return minus 0.03% expense ratio). This means investors holding EEM would likely lag the S&P 500 ETF, even if the underlying EM index outperforms, unless they opt for lower-cost EM alternatives (e.g., Schwab Emerging Markets Equity ETF, SCHE, 0.11% expense ratio, net 7.39% projected return). By contrast, VIOO’s 0.07% expense ratio leaves its net projected return at 7.53%—a 46 basis point premium to VOO—making it the more credible pick for outperformance. VIOO’s thesis is bolstered by FactSet’s 2026 earnings forecast: U.S. small-cap earnings are set to grow faster than large-caps for the first time in six years, driven by operational leverage in industrial and consumer discretionary sectors (30% of VIOO’s assets) and a 25% forward P/E discount to large-caps, per State Street’s valuation analysis. For EEM, while U.S. dollar devaluation is a plausible 3–5 year tailwind (driven by widening U.S. fiscal deficits and Fed normalization post-2026), the fund’s 28% exposure to China (per MSCI index data) introduces unquantified regulatory and geopolitical risk, a gap in State Street’s analysis. Additionally, EM tech stocks (32% of EEM’s assets) face intensifying competition from U.S. large-caps in semiconductor and e-commerce markets, which could cap earnings growth. Finally, VIOO’s year-to-date outperformance (double the S&P 500) is tied to earlier rate cut hopes, but the Iran conflict has pushed rate cut expectations to 2027. Since small-caps rely on floating-rate debt for 35% of their funding (per S&P Global), a prolonged high-rate environment could erase earnings gains and reverse VIOO’s near-term outperformance, even if the 3–5 year thesis holds. (Word count: 1,187) iShares MSCI Emerging Markets ETF (EEM) – State Street’s 3–5 Year Outperformance Thesis vs. S&P 500{随机描述}{随机描述}iShares MSCI Emerging Markets ETF (EEM) – State Street’s 3–5 Year Outperformance Thesis vs. S&P 500{随机描述}